Key result
Pulmonary artery intimal angiosarcoma presented with a maximum SUV of 0.90 on 18F-FDG PET-CT and showed no size reduction after 3 weeks of anticoagulation, requiring left pneumonectomy.
Why the study?
Pulmonary artery sarcoma is often difficult to differentiate from pulmonary embolism, and while 18F-FDG PET is typically useful, rare cases undetectable by PET can occur.
Case Report (n=1)
No
A negative 18F-FDG PET-CT result and lack of contrast enhancement on CT or MRI do not rule out pulmonary artery intimal angiosarcoma in patients presenting with suspected pulmonary thromboembolism and negative D-dimer.
Answers are grounded in this paper and cite their sources.
Negative 18F-FDG PET-CT does not exclude pulmonary artery intimal angiosarcoma; leaves open need for tissue diagnosis in non-resolving lesions.
Background Pulmonary artery sarcoma is a rare malignant neoplasm arising from intimal mesenchymal cells in the pulmonary artery wall and is often difficult to differentiate from pulmonary embolism, however, 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) can be useful for a differential diagnosis. Here, we present a rare case of pulmonary sarcoma undetectable by PET. Case summary A 77-year-old woman who had worsening dyspnoea on effort for a month and progressive chest discomfort with nocturnal cough for a week presented to our hospital. Contrast-enhanced computed tomography (CT) demonstrated a massive filling defect in the left pulmonary artery (PA). Two major differential diagnoses were considered; pulmonary thromboembolism and tumour-like lesions. Positron emission tomography-computed tomography (PET-CT) revealed that there was no abnormal accumulation of 18F-FDG in the mass. However, even after effective anti-thrombotic treatment for 3 weeks, a follow-up CT showed no reduction at all in the size of the lesion in the pulmonary artery. Therefore, surgery for diagnostic therapeutic purposes was performed. Discussion The present case is informative because it supports the idea that being aware of PA angiosarcoma as a potential differential diagnosis of pulmonary thromboembolism is essential, particularly in cases of no evident peripheral venous thrombosis and a negative D-dimer test, even if neither heterogenous contrast enhancement in CT and magnetic resonance imaging nor accumulation of 18-FDG in PET-CT is evident.
No takes yet. Share an insight, caveat, or question.
Koike et al. (2023) conducted a case report in Pulmonary artery intimal angiosarcoma mimicking pulmonary thromboembolism (n=1). Left pneumonectomy and adjuvant radiation therapy following initial anticoagulation (unfractionated heparin then apixaban) was evaluated on Event-free survival following surgical resection and adjuvant radiation. Pulmonary artery intimal angiosarcoma presented with a maximum SUV of 0.90 on 18F-FDG PET-CT and showed no size reduction after 3 weeks of anticoagulation, requiring left pneumonectomy.
Synapse has enriched 10 related papers. Consider them for comparative context: